LONGMONT, Colo. and WALTHAM, Mass., Nov. 30, 2023 /PRNewswire/ — KromaTiD and SeQure Dx announced today a partnership to market a comprehensive and integrated analysis of off-target gene editing in support of cell and gene therapy research, Investigational New Drug (IND) applications and…
